17 nov: Tivoli A/S - Fondsbørsmeddelelse nr. 13 – 17.11.2016 - Finanskale..
18 nov: Indre værdi af SmallCap Danmark A/S er opgjort til 80,8 kr. pr. ..
18-11-2016 08:00:44

H+H International A/S - Interim financial report Q1-Q3 2016

Relateret indhold
19 dec - 
Tirsdagens aktier: Plus til FLS og Pandora kunne ikke h..
19 dec - 
Aktier/middag: Mærsk og FLS trækker C25 mod fremgang ig..
19 dec - 
Aktier/åbning: Mærsk i top og Vestas i bund
Relateret debat
04 jan - 
Ja - nu skuffer den ikke mere - næsten 50% stigning på ..

Copenhagen, Denmark, 2016-11-18 08:00 CET (GLOBE NEWSWIRE) --

 

H+H International A/S

Dampfærgevej 3, 3rd Floor

2100 Copenhagen Ø

Denmark

Tel.: +45 35 27 02 00

www.HplusH.com

Company reg. no. 49 61 98 12

 

Highlights for the period Q1-Q3 2016

  • Revenue for the third quarter increased by 4% in local currencies (organic growth) and decreased by 5% in Danish kroner to DKK 438.7 million. Revenue for the first three quarters increased by 8% in local currencies (organic growth) and by 1% in Danish kroner to DKK 1,264.1 million.

  • EBITDA before special items for the third quarter was DKK 63.7 million (2015: DKK 62.7 million). EBITDA for the first three quarters was DKK 166.1 million before special items (2015: DKK 141.0 million).

  • EBIT before special items for the third quarter was DKK 44.9 million (2015: DKK 37.6 million). The EBIT was DKK 104.8 million before special items for the first three quarters (2015: DKK 68.8 million). EBIT margin before special items for the third quarter was 10.2% (2015: 8.2%), and EBIT margin before special items for the first three quarters was 8.3% (2015: 5.5%).

  • The third quarter brought a net profit of DKK 31.6 million (2015: DKK 4.3 million). Net profit for the first three quarters reached DKK 61.7 million (2015: 30.0 million).

  • Investments of DKK 23.0 million were made in the third quarter (2015: DKK 14.2 million) and DKK 38.2 million in the first three quarters of the year (2015: DKK 39.9 million).

  • Free cash flow for the third quarter was DKK 50.9 million (2015: DKK 84.4 million), and for the first three quarters DKK 75.5 million (2015: DKK 14.0 million).

  • Net interest-bearing debt at 30 September 2016 was DKK 385.0 million (30 September 2015: DKK 476 million).

  • H+H reiterates its outlook for 2016. Organic revenue growth is expected to be 5-6% (measured in local currencies), and EBITDA before special items is expected to be DKK 190-210 million. Investments excluding acquisitions and divestments are expected to be in the region of DKK 80 million.

Quote:

“We continue to see progress across our markets, and despite the headwind from the decline in the GBP, our earnings have improved over last year”, says Michael T Andersen, CEO. “The positive market development supports our pricing strategy, and in combination with cost containment, we have mitigated the external negative factors from adverse currency effect and increase in raw material costs in the UK.”

Please see attached PDF for full version of the report.

 

Kent Arentoft

Chairman of the Board of Directors

Michael T Andersen

CEO

 

For additional information please contact:

Michael T Andersen, CEO, or Bjarne Pedersen, Vice President, Business Development & IR, tel.: +45 35 27 02 00.

Vedhæftet fil: 343_UK-Q1-Q3_2016.pdf

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Novo Nordisk/Goldman: Diabetestablet vil få den høje vækst tilbage

19-01-2018 15:11:36
Novo Nordisk står med et meget stærkt kort på hånden, hvis selskabet får en tabletudgave af det store væksthåb Ozempic (Semaglutid) godkendt og sendt på markedet.Det mener den amerikanske investeringsbank Goldman Sachs, der vurderer, at investorerne på aktiemarkedet ikke har taget tilstrækkeligt højde for de store muligheder for diabetesmidlet.Derfor har banken hævet sit kursmål for Novo Nordisk-a..

WDH/SEB: Amerikansk høreapparatmarked vokser mere end ventet

19-01-2018 14:35:39
Der var mere fart på den private del af det amerikanske høreapparatmarked i slutningen af 2017, end den svenske bank SEB havde ventet.Det skriver Bloomberg News på baggrund af en analyse fra SEB.Den private del af det amerikanske høreapparatmarked voksede 7,3 pct. i fjerde kvartal mod 2,8 pct. i tredje kvartal ifølge tal fra American Hearing Aid Association. Det var højere, end SEB har ventet, og ..

Aktier/åbning: Børshuse skubber Chr. Hansen og Novo til tops

19-01-2018 09:23:02
Chr. Hansen og Novo Nordisk er strøget til tops på det danske aktiemarked og medvirker til at hive det danske C25-indeks i et solidt plus fredag morgen.Stemningen var ellers svagt negativ i futuremarkedet indtil kort før åbningen.C25-indekset stiger 0,5 pct. til 1160,09 og ligger til et samlet plus på 0,8 pct. i denne uge.Især Chr. Hansen er sprunget i vejret fra åbningen. Aktien stiger 3,9 pct. t..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge

Relaterede aktiekurser

H+H International A/S 155,40 0,0% Aktiekurs uændret

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2018  Disclaimer Privatlivspolitik
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
20. januar 2018 20:19:06
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20180112.1 - EUROWEB2 - 2018-01-20 20:19:06 - 2018-01-20 20:19:06 - 1 - Website: OKAY